The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2017

Filed:

May. 10, 2012
Applicants:

Steven A. Greenberg, Newton, MA (US);

Mohammad K. Salajegheh, Boston, MA (US);

Inventors:

Steven A. Greenberg, Newton, MA (US);

Mohammad K. Salajegheh, Boston, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/543 (2006.01); G01N 33/564 (2006.01); C12N 9/16 (2006.01);
U.S. Cl.
CPC ...
G01N 33/54306 (2013.01); C12N 9/16 (2013.01); G01N 33/564 (2013.01); C07K 2319/00 (2013.01); C07K 2319/21 (2013.01); C07K 2319/23 (2013.01); C07K 2319/43 (2013.01); G01N 2333/46 (2013.01); G01N 2800/10 (2013.01); G01N 2800/52 (2013.01);
Abstract

Methods, devices, kits and systems for diagnosing inclusion body myositis (IBM) are provided. Methods, devices, kits and systems involves detecting the presence and/or level of autoantibodies that are reactive against at least a ˜43 kilodalton (kDa) protein or ˜43 kDa protein band from a muscle lysate or a mammalian cell lysate, or autoantibodies that are reactive against a cytosolic 5'-nucleotidase 1A protein (NT5C1A), or a cytosolic 5′-nucleotidase 1B protein (NT5C1B), or a NT5C1B isoform thereof, or a peptide fragment thereof, an isolated peptide thereof or a fusion protein comprising an isolated peptide of NT5C1A or NT5C1B. Such autoantibodies are only found in IBM patients and not in patients with other myopathies.


Find Patent Forward Citations

Loading…